Correction of an in vitro immunoregulatory defect in atopic subjects by the immunostimulating drug fanetizole mesylate (CP-48,810)
Authors:
- 1 January 1984
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 6 (1) , 1-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- IgE production in vitro by human blood mononuclear cells: a comparison between atopic and nonatopic subjectsJournal of Allergy and Clinical Immunology, 1983
- Human monocyte-derived soluble product(s) has an accessory function in the generation of histamine- and concanavalin A-induced suppressor T cells.Journal of Clinical Investigation, 1982
- Cellular interactions in the generation and expression of histamine-induced suppressor activityCellular Immunology, 1982
- Abnormal Histamine-Induced Suppressor-Cell Function in Atopic SubjectsNew England Journal of Medicine, 1982
- Histamine modulates in vitro IgG production by pokeweed mitogen-stimulated human mononuclear cellsCellular Immunology, 1981
- Characterization of the human blood lymphocytes that produce a histamine-induced suppressor factor (HSF)Cellular Immunology, 1980
- Abnormalities in the Regulation of Human IgE SynthesisImmunological Reviews, 1978
- T Lymphocyte Numbers and Function in Human IgE‐Mediated AllergyImmunological Reviews, 1978
- Mechanisms of Reaginic Hypersensitivity and IgE Antibody ResponseImmunological Reviews, 1978
- The Allergic Phenotype: Manifestation of‘Allergic Breakthrough’and Imbalance in Normal‘Damping’of IgE Antibody ProductionImmunological Reviews, 1978